Literature DB >> 7954325

Two subclones in a case of uveal melanoma. Relevance of monosomy 3 and multiplication of chromosome 8q.

G Prescher1, N Bornfeld, R Becher.   

Abstract

Monosomy 3 and multiplication of 8q are nonrandom findings in uveal melanoma. We present a case in which two subclones could be detected. Both had monosomy 3 in common. Furthermore, a multiplication of chromosome 8 material was also seen in both subclones. However, it was based on different kinds of aberrations and was accompanied by further anomalies, such as loss of a Y-chromosome, an additional chromosome 7, and an additional marker chromosome, in only one clone. This finding allows some insight into the relevance of the most frequently found anomalies of chromosome 3 and 8 in uveal melanoma. As monosomy 3 occurred before any subclone differentiation, it must be an early, if not primary, event in the genesis of this tumor. Multiplication of chromosome 8, specifically of 8q, however, may contribute to the clonal evolution of this tumor.

Entities:  

Mesh:

Year:  1994        PMID: 7954325     DOI: 10.1016/0165-4608(94)90230-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 2.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

3.  Choroidal melanoma.

Authors:  Parul Singh; Abhishek Singh
Journal:  Oman J Ophthalmol       Date:  2012-01

4.  Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.

Authors:  N Soufir; B Bressac-de Paillerets; L Desjardins; C Lévy; J Bombled; I Gorin; P Schlienger; D Stoppa-Lyonnet
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

5.  Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma.

Authors:  K Sisley; M A Parsons; J Garnham; A M Potter; D Curtis; R C Rees; I G Rennie
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

6.  Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.

Authors:  P G Corrie; J Shaw; V J Spanswick; R Sehmbi; A Jonson; A Mayer; R Bulusu; J A Hartley; I A Cree
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

Review 7.  Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma.

Authors:  Mark J de Lange; Rogier J Nell; Pieter A van der Velden
Journal:  Mol Biomed       Date:  2021-08-20

8.  Case report: an atypical peripapillary uveal melanoma.

Authors:  Li-Anne Lim; Cristina Miyamoto; Paula Blanco; Silvin Bakalian; Miguel N Burnier
Journal:  BMC Ophthalmol       Date:  2014-02-03       Impact factor: 2.209

9.  Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.

Authors:  Mieke Versluis; Mark J de Lange; Sake I van Pelt; Claudia A L Ruivenkamp; Wilma G M Kroes; Jinfeng Cao; Martine J Jager; Gre P M Luyten; Pieter A van der Velden
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.